Literature DB >> 2458944

CD4+CD45R+ cells are preferentially activated through the CD2 pathway.

T Matsuyama1, P Anderson, J F Daley, S Schlossman, C Morimoto.   

Abstract

CD4 cell subsets, CD4+CD45R+ (CDw29-) cells and CD4+CD45R- (CDw29+) cells, can be differently triggered by various stimuli and possess distinct functions. In the present study, cell activation in CD4+CD45R+ and CD4+CD45R- subsets mediated by CD3-Ti antigen-receptor complex or CD2 molecule were examined by using anti-CD3 antibody or pairs of anti-CD2 antibodies (anti-T11(2) and anti-T11(3) antibodies). The results showed that CD4+CD45R+ cells were preferentially activated through the CD2 pathway, whereas both subsets were equally activated through the CD3-Ti antigen-receptor pathway when a second signal such as monocytes or interleukin 2 was present. The different responsiveness of CD4+CD45R+ and CD4+CD45R- subsets through the CD2 molecule did not appear to be due to differences in the distribution or number of T11(2) and T11(3) determinants. These data suggest that some part of the functional diversity of CD4 cell subsets might be explained by the differences in cell activation through the CD2 molecule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458944     DOI: 10.1002/eji.1830180926

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

Review 1.  Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation.

Authors:  L T Clement
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

2.  CD2-mediated stimulation of the naive CD4+ T-cell subset promotes the development of skin-associated cutaneous lymphocyte antigen-positive memory cells.

Authors:  L Liu; A Foer; J Sesterhenn; U Reinhold
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

3.  Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.

Authors:  R Gerli; A Bertotto; E Agea; L Lanfrancone; C Cernetti; F Spinozzi; P Rambotti
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

4.  Anti-leucocyte common (CD45) antibodies inhibit dendritic cell stimulation of CD4 and CD8 T-lymphocyte proliferation.

Authors:  T C Prickett; D N Hart
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

5.  Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells.

Authors:  D L Wallace; P C Beverley
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

6.  CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cells.

Authors:  U Reinhold; L Liu; J Sesterhenn; H Abken
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

7.  Age-related increase in the fraction of CD27-CD4+ T cells and IL-4 production as a feature of CD4+ T cell differentiation in vivo.

Authors:  E W Nijhuis; E J Remarque; B Hinloopen; T Van der Pouw-Kraan; R A Van Lier; G J Ligthart; L Nagelkerken
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

8.  Defective CD2 T cell pathway activation in common variable immunodeficiency (CVID).

Authors:  S Zielen; T J Dengler; P Bauscher; S C Meuer
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex.

Authors:  T Matsuyama; A Yamada; J Kay; K M Yamada; S K Akiyama; S F Schlossman; C Morimoto
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

10.  Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory.

Authors:  S Ehlers; K A Smith
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.